Additionally, we report the design, synthesis and in vitro and in vivo characterization of a new class of SHP ligands based on the isoxazole scaffold that attenuates HSC trans-differentiation and development of fibrosis in a mice model of liver injury, highlighting a potential role for SHP ligands in the treatment of hepatic fibrosis. Here, NR0B2 is linked to fibrosis.